See the results of how far visitors Scroll down
Update, February 25 2026, 4:35PM ET: This story has been updated to include more details on the Perplexity AI integration, as well as include mentions in the intro of our hands-on and pre-order articles.，详情可参考搜狗输入法2026
有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。，更多细节参见谷歌浏览器【最新下载地址】
Startups are the core of TechCrunch, so get our best coverage delivered weekly.。关于这个话题，爱思助手下载最新版本提供了深入分析